
    
      Metastatic gastric cancer, progressive disease after one palliative chemotherapy

      Arm A:

      Irinotecan 250/350 mg/m2 q3w

        1. Cycle:250mg/m2/ 30min

        2. Cycle:If no toxicity>2° CTC, nor Leuko-thrombopenia>3° occured, dose is increased to
           350mg/m2 Arm B. Best supportive care
    
  